NASDAQ · HSCSFinancialsBanking & Credit

HeartSciences news

$4.05−8.58%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral00%
Negative1100% of coverage

About HeartSciences

HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment ResearchSep 14, 5:35 PM ET▼ Negative

Company missed EPS consensus estimate by 10.26% and posted zero revenues, missing revenue estimates by 97.9%. Assigned Zacks Rank #3 (Hold) with mixed estimate revisions, indicating underperformance relative to market expectations.

Also mentions HSCS

Articles that tag HSCS but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology